CVS Health Corp.

CVS · NYSE · USD

Analyst consensus

Buy41 analysts

Bearish · 0 · Hold · 6 · Bullish · 35

Earnings history

	EPS	Estimate
Q3 2024	$1.09	$1.44	Miss
Q4 2024	$1.19	$0.91	Beat
Q1 2025	$2.25	$1.70	Beat
Q2 2025	$1.81	$1.46	Beat
Q3 2025	$1.60	$1.37	Beat
Q4 2025	$1.09	$1.00	Beat
Q1 2026	$2.57	$2.18	Beat
Q2 2026	$2.58	$1.85	Beat

Peers

Company overview

IPO dateFeb 21, 1973

CEOJ. David Joyner

Employees259,500

SectorHealthcare

IndustryMedical - Healthcare Plans

CountryUS

ExchangeNew York Stock Exchange

Websitewww.cvshealth.com

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.